L. Smith
Nessuna posizione attualmente
Patrimonio netto: 9 M $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Saqib Islam | M | 54 | 7 anni | |
| Alan Fuhrman | M | 67 | 5 anni | |
| Herschel Weinstein | M | 68 | 4 anni | |
| Freda Lewis-Hall | M | 69 | 7 anni | |
| Carlos Alban | M | 61 | 2 anni | |
| Judy Olian | M | 72 | 9 anni | |
| Julie Hambleton | M | 66 | 4 anni | |
| Badreddin Edris | M | 37 | 6 anni | |
| Kim Diamond | F | - | 6 anni | |
| Frank Perier | M | 64 | 5 anni | |
| Michael Nofi | M | 53 | 5 anni | |
| Daniel Pichl | M | 41 | 4 anni | |
| Bhavesh Ashar | M | 58 | 3 anni | |
| James Cassidy | M | 65 | 3 anni | |
| Tai-An Lin | M | 61 | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| John Maxim Ferrari | M | 69 | 14 anni | |
| Sheila Mikhail | F | 57 |
Bamboo Therapeutics, Inc.
 Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 2 anni |
| Deval Patrick | M | 67 | 2 anni | |
| Stephen P. Squinto | M | 67 | 5 anni | |
| Carl Gordon | M | 59 | 2 anni | |
| Michael V. Greco | M | 53 | 1 anni | |
| Jeffrey Schwartz | M | 45 | 6 anni | |
| Josh Grieger | M | - |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 3 anni |
| Michael Burgess | M | 61 | 1 anni | |
| Rhonda L. Stanley | F | 64 |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 1 anni |
| Renu Vaish | F | - | - | |
| Alex Sapir | M | 57 | 10 anni | |
| Jens Renstrup | M | 59 | 3 anni | |
| Scott Moomaw | M | 54 | 5 anni | |
| Paul Herzich | M | 46 |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 2 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 30 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- L. Smith
- Contatti personali
